Study S000205

Investigation of the Safety and Efficacy of Once Weekly NNC0519-0130 in Participants With Overweight or Obesity - a Dose Finding Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06326060
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 354
Start: 2024-03-18
Primary completion: 2025-04-10
Lead sponsor: Novo Nordisk A/S
Conditions: Obesity
Interventions: DRUG:NNC0519-0130; DRUG:Placebo; DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1291-9210; REGISTRY:jRCT2051230198

Registered primary outcomes

Relative change in body weight [From baseline (week 0) to end of treatment (week 36)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.